Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 4, 2012, Pages 312-314

  Chien, Jaime Mei Fong ^a   Koh, Tse Hsien ^a   Chan, Kian Sing ^a   Chuah, Thuan Heng Charles ^a   Tan, Thuan Tong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

NDM 1; neutropenia; polymyxin; stool surveillance; treatment

Indexed keywords

AZTREONAM; BETA LACTAMASE; MEROPENEM; NEW DELHI METALLO BETA LACTAMASE 1; POLYMYXIN B; UNCLASSIFIED DRUG; VANCOMYCIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MULTIDRUG RESISTANCE; NEUTROPENIA;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; NEUTROPENIA; POLYMYXIN B;

EID: 84858971253     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.633549     Document Type: Article

References (14)

1. NDM-1 gene by real-time PCR. J Antimicrob Chemother 2011;66:1647-9.
2. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
3. Struelens MJ, Monnel DL, Magiorakos AP, Santos O'Connor F, Giesecke J; European NDM-1 Survey participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010;15. pii 19716.
4. Kumarasamy KK, Toleman MA, Walsh TR, Bageria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
5. Chan HL, Poon LM, Chan SG, Teo JW. The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist. Singapore Med J 2011;52:299-302.
6. Koh TH, Khoo CT, Wijaya L, Leong HN, Lo YL, Lim LC, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010;10:828.
7. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practise guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56-93.
8. Wong GC, Tan BH. Use of antibiotics in a haematological ward - an audit. Ann Acad Med Singapore 2008;37:21-6.
9. Jin J, Yee ML, Ding Y, Koh LP, Lim SE, Lim R, et al. Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore. Ann Acad Med Singapore 2010;39:453-9.
10. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-36.
11. Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capitano B, et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007;59:128-31. (Pubitemid 46017915)
12. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 2011;69:357-62.
13. Daly MW, Riddle DJ, Ledeboer NA, Dunne WM, Ritchie DJ. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy 2007;27:1052-7. (Pubitemid 46986692)
14. Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007;60:1206-15. (Pubitemid 350168315)